Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 11/20 | 0.54 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.53 |
| ▸ | RAB9A | P51151 | 3/20 | 0.48 |
| ▸ | NPC1 | O15118 | 2/20 | 0.48 |
| ▸ | MAPT | P10636 | 1/20 | 0.48 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9739829 | 0.86 | ALOX5 (0.60) | ALOX5ALOX15KDM4EALDH1A1 | |
| SCHEMBL3609288 | 0.86 | RAB9A (0.50) | ALOX5ALOX15RAB9ANPC1MAPT | |
| SCHEMBL9739459 | 0.85 | ALOX5 (0.53) | ALOX5ALOX15RAB9ANPC1MAPT | |
| SCHEMBL9740227 | 0.79 | ALOX5 (0.65) | ALOX5ALOX15RAB9ANPC1MAPT | |
| SCHEMBL10738818 | 0.78 | RAB9A (0.60) | ALOX5RAB9ANPC1MAPTL3MBTL1 | |
| SCHEMBL10863363 | 0.78 | L3MBTL1 (0.54) | ALOX15RAB9ANPC1MAPTL3MBTL1 | |
| SCHEMBL10739810 | 0.76 | RAB9A (0.58) | ALOX15RAB9ANPC1MAPTL3MBTL1 | |
| SCHEMBL3609779 | 0.76 | L3MBTL1 (0.48) | ALOX5RAB9ANPC1MAPTL3MBTL1 | |
| SCHEMBL10745259 | 0.75 | ALOX5 (0.48) | ALOX5ALOX15RAB9ANPC1MAPT | |
| SCHEMBL3614948 | 0.74 | RAB9A (0.62) | ALOX5RAB9ANPC1MAPTL3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0200443-B1 | LIPOXYGENASE INHIBITORS | MERCK FROSST CANADA INC. (CA) | 1989-03-01 | — | — | EP | claimed |
| EP-0200443-A1 | Lipoxygenase inhibitors | MERCK FROSST CANADA INC. (CA) | 1986-11-05 | — | — | EP | claimed |
| US-5087638-A | Inhibitors of mammalian leukotriene biosynthesis | MERCK FROSST CANADA, INC. (CA) | 1992-02-11 | — | — | US | disclosed |
| EP-0338782-A1 | Benzofuran derivatives | MERCK FROSST CANADA INC. (CA) | 1989-10-25 | — | — | EP | disclosed |
| US-4863958-A | TREATING ALLERGIC CONDITIONS, ASTHMA, CARDIOVASCULAR DISORDERS, AND INFLAMMATION | MERCK FROSST CANADA, INC. (CA) | 1989-09-05 | — | — | US | disclosed |
| EP-0165810-B1 | BENZOFURAN AND BENZOTHIOPHENE DERIVATIVES, THEIR USE IN INHIBITING MAMMALIAN LEUKOTRIENE BIOSYNTHESIS, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THESE DERIVATIVES | MERCK FROSST CANADA INC. (CA) | 1989-08-23 | — | — | EP | disclosed |
| EP-0200443-B1 | LIPOXYGENASE INHIBITORS | MERCK FROSST CANADA INC. (CA) | 1989-03-01 | — | — | EP | disclosed |
| US-4663347-A | ANTIINFLAMMATORY, ANTIALLERGENS, CARDIOVASCULAR | MERCK FROSST CANADA, INC. (CA) | 1987-05-05 | — | — | US | disclosed |
| EP-0200443-A1 | Lipoxygenase inhibitors | MERCK FROSST CANADA INC. (CA) | 1986-11-05 | — | — | EP | disclosed |
| EP-0165810-A2 | Benzofuran and benzothiophene derivatives, their use in inhibiting mammalian leukotriene biosynthesis, and pharmaceutical compositions containing these derivatives | MERCK FROSST CANADA INC. (CA) | 1985-12-27 | — | — | EP | disclosed |